Fraga et al. found that the CpG island in the TLE1 gene promoter is frequently hypermethylated, causing epigenetic inactivation of TLE1 in various blood tumor cells, including AML, chronic myeloid leukemia (CML), and non-Hodgkin’s lymphoma (Fraga et al., 2008). This evidence concerns the gene TLE1 and neoplasm.